Loading...
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
Ovarian cancer is the most lethal gynecologic malignancy. Surgery and chemotherapy are the primary treatments for ovarian cancer; however, patients often succumb to recurrence with chemotherapeutic resistance within several years after the initial treatment. In the past two decades, immunotherapy ha...
Na minha lista:
| Udgivet i: | Front Immunol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572849/ https://ncbi.nlm.nih.gov/pubmed/33123161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.577869 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|